Form 4: Arteris Director Wayne Cantwell Sells 38,500 Shares
Statement of Changes in Beneficial Ownership
Arteris, Inc. Director Wayne C. Cantwell sold 38,500 shares of common stock at a weighted average price of $37.2251.
Summary
- Director Wayne C. Cantwell sold 38,500 shares of Arteris, Inc. (AIP) common stock.
- The transaction occurred on May 26, 2026.
- The shares were sold at a weighted average price of $37.2251, with individual trade prices ranging from $36.79 to $37.55.
- The shares were held indirectly through The Cantwell Living Trust.
- Following the transaction, the reporting person retains 189,698 shares in the trust, plus 34,732 shares held directly and 38,761 shares held in a 401K plan.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event; it is a standard disclosure of insider liquidity management that does not inherently reflect on the company's operational health.
Positives
- The director maintains a significant remaining equity stake in the company totaling 263,191 shares across various accounts.
Negatives
- Insider selling can sometimes be perceived by the market as a lack of confidence in near-term share price appreciation.
Risks
- Market volatility affecting the share price of AIP.
Future Outlook
No forward-looking guidance or operational outlook was provided in this regulatory filing.
Industry Context
StockSavvy.ai notes that insider selling is a routine corporate governance event. While large sales can draw attention, they are often part of pre-planned 10b5-1 trading programs or personal financial diversification strategies rather than indicators of company performance.
Comparison to Industry Standards
- Insider transactions are common in the semiconductor and technology sectors as part of standard executive compensation and liquidity management.
- The remaining holdings of the director suggest a continued alignment of interests with shareholders.
Stakeholder Impact
- Minimal impact expected on shareholders as this is a routine disclosure of director equity movement.
Next Steps
- No future actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 05/26/2026 | Date of the reported stock sale transaction. |
| 05/27/2026 | Date the Form 4 was signed and filed. |
Keywords
Arteris, AIP, Insider Trading, Form 4, Semiconductor, Equity Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.